The FDA has released draft guidance outlining the process for reviewing low-risk medical devices seeking approval under the 510(k) program. The guidance is up for comment through April 26. The Hill/Healthwatch blog
Advertisement
The FDA has released draft guidance outlining the process for reviewing low-risk medical devices seeking approval under the 510(k) program. The guidance is up for comment through April 26. The Hill/Healthwatch blog
